Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy

Kanat, O; Ertas, H

Kanat, O (reprint author), Uludag Univ, Dept Med Oncol, Fac Med, TR-16059 Gorukle, Bursa, Turkey.

WORLD JOURNAL OF CLINICAL ONCOLOGY, 2019; 10 (2): 52

Abstract

Continuous inhibition of angiogenesis beyond progression is an emerging treatment concept in the management of metastatic colorectal cancer patients w......

Full Text Link